Infographic | September 11, 2023

Why Choosing A Client-Centric CTDMO Is Critical When Outsourcing Biomanufacturing Projects

Doctor businessman shaking hands GettyImages-1098284154

Biologic drug development, encompassing monoclonal antibodies and other large molecules produced in mammalian cells, is experiencing significant growth. While certain biologic drugs have established manufacturing processes, biomanufacturers still face a number of challenges and bottlenecks with bioprocess optimization, capacity limitations, supply chain hurdles, and regulatory requirements.

A promising solution for companies that lack the technical expertise and comprehensive in-house capacity to address these issues is outsourcing various drug development phases to an end-to-end specialized Contract Testing, Development, and Manufacturing Organization (CTDMO). A CTDMO can serve as either a service provider or a collaborative partner in strategic thinking. Thus, selecting the right CTDMO partner is crucial for the success of the biomanufacturing project.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online